Healthcare Value Capital as of Dec. 31, 2014
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 22 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Albany Molecular Research | 21.4 | $12M | 718k | 16.28 | |
| AstraZeneca (AZN) | 12.9 | $7.0M | 100k | 70.38 | |
| Teva Pharmaceutical Industries (TEVA) | 10.5 | $5.8M | 100k | 57.51 | |
| Quest Diagnostics Incorporated (DGX) | 9.5 | $5.2M | 77k | 67.07 | |
| Pfizer (PFE) | 8.5 | $4.7M | 150k | 31.15 | |
| Ultra Short Russell 2000 | 7.2 | $4.0M | 100k | 39.59 | |
| Ligand Pharmaceuticals In (LGND) | 4.9 | $2.7M | 50k | 53.22 | |
| CryoLife (AORT) | 4.1 | $2.3M | 200k | 11.33 | |
| Qlt | 3.7 | $2.0M | 500k | 4.01 | |
| Sorrento Therapeutics (SRNEQ) | 3.3 | $1.8M | 181k | 10.07 | |
| Ariad Pharmaceuticals | 3.1 | $1.7M | 250k | 6.87 | |
| Cempra | 1.7 | $940k | 40k | 23.50 | |
| Rigel Pharmaceuticals (RIGL) | 1.7 | $908k | 400k | 2.27 | |
| Alimera Sciences | 1.5 | $831k | 150k | 5.54 | |
| Cytokinetics (CYTK) | 1.5 | $801k | 100k | 8.01 | |
| Sunesis Pharmaceuticals | 0.9 | $510k | 200k | 2.55 | |
| Amarin Corporation (AMRN) | 0.9 | $490k | 500k | 0.98 | |
| Fibrocell Science | 0.8 | $409k | 158k | 2.59 | |
| Pozen | 0.7 | $400k | 50k | 8.00 | |
| D Stemline Therapeutics | 0.5 | $281k | 17k | 17.07 | |
| Celsion Corporation | 0.4 | $233k | 100k | 2.33 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.3 | $149k | 50k | 2.98 |
